Wockhardt Looking to Complete Phase III Trials for Zaynich
The Indian pharma company, Wockhardt Ltd, on Wednesday, 29 May, said that the Phase III clinical trial for Zaynich (Zidebactam/Cefepime) is expected to be completed...
Use UNICORN Signals App
By EquityPandit
